Overview and Financials

Stock Information

Investor and Media Relations

Anthony Marciano
Head of Corporate Communications
Seelos Therapeutics, Inc.
anthony.marciano@seelostx.com

Offices
Seelos Therapeutics, Inc.
300 Park Avenue
New York, NY 10022

Incorporated
Nevada

Entity type
Corporation

Identifiers
CIK:1017491
IRS:870449967

Receive Email Alerts

Seelos Sitemap

Overview

Seelos Therapeutics, Inc. (Nasdaq: SEEL) is a responsibly-driven company focused on achieving the most efficient development of products that address significant unmet needs in CNS disorders and in rare diseases.

Seelos Therapeutics Corporate Presentation

Press Releases

Stock Price Chart